Survivin and REG gene expression as prognostic marker

摘要

An assay system for identifying the existence of a product or products of, in combination, the REG and Survivin genes, so as to determine the tendency of a tissue to become cancerous or the aggressive nature of an existing cancer with a view to determining prognosis and/or therapy. A method of screening individuals for the existence of a product or products of, in combination, the REG and Survivin genes, so as to determine whether the patient should be included or excluded in a clinical trial.